Iconic Therapeutics has appointed Brandon Smith chief operating officer. South San Francisco, CA-based Iconic is developing therapies for retinal disease and cancer. Smith comes to Iconic from Hayward, CA-based Impax Laboratories (NASDAQ: [[ticker:IPXL]]), where he was senior vice president of corporate development and strategy. Before Impax, Smith was an executive director at Amgen (NASDAQ: [[ticker:AMGN]]), where he worked on biosimiliar business development.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
